{"pmid": "12663718", "sentences": {"sent_1": {"Section": "", "text": "PATIENTS AND METHODS : Twenty patients who had not received prior therapy for metastatic disease were treated with 300 mg of R115777 orally every 12 hours for 21 of 28 days .", "entities": {"entity_1": {"text": "metastatic disease", "class": "Participant", "negation": 0, "UMLS": "C0027627:metastatic disease,", "index": 1, "start": 13}, "attribute_1": {"text": "300 mg", "class": "measure", "negation": 0, "UMLS": "", "index": 2, "start": 18}, "entity_2": {"text": "R115777", "class": "Intervention", "negation": 0, "UMLS": "C0393031:r115777,", "index": 3, "start": 21}}, "relations": {}}, "sent_2": {"Section": "", "text": "Inhibition of FTase activity in peripheral - blood mononuclear cells was measured using a lamin B C - terminus peptide as substrate .", "entities": {"entity_3": {"text": "Inhibition of FTase activity", "class": "Outcome", "negation": 0, "UMLS": "C0021467:Inhibition,", "index": 1, "start": 0}, "entity_4": {"text": "peripheral - blood mononuclear cells", "class": "Participant", "negation": 0, "UMLS": "C0005767:blood,C1513475:Mononuclear,", "index": 2, "start": 5}}, "relations": {}}, "sent_3": {"Section": "", "text": "Western blot analysis was performed to monitor farnesylation status of the chaperone protein HDJ - 2 .", "entities": {}, "relations": {}}}}